PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
17-Jan-2023 ImmunOs Therapeutics Receives Regulatory Approval for First-In-Human Trial of IOS-1002 ImmunOs Therapeutics
11-Jan-2023 HighTide Therapeutics Announces First Patient Dosed in Phase 2b Clinical Study Evaluating HTD1801 in NASH (the CENTRICITY study) HighTide Therapeutics Inc.
11-Jan-2023 Ethics Approval granted for significant Ultra Pure Synthetic CBD Phase III Efficacy Clinical Trial Chanelle McCoy Health
10-Jan-2023 Symeres acquires Oncolines, further strengthening its drug discovery and biology capabilities Symeres
10-Jan-2023 Phastar enhances Data Visualization and Analytics solution through acquisition of S-Cubed ApS, adds capability in Denmark Phastar
09-Jan-2023 Quanticate makes key appointment to bolster leadership team Quanticate
06-Jan-2023 Egnyte to provide early-stage life science startups a year of Egnyte’s platform at no cost Egnyte
06-Jan-2023 New AI editing tool to speed up editing manuscripts Cactus Communications
05-Jan-2023 STEMart Introduces API Impurity Identification Services for Medical Devices STEMart
05-Jan-2023 CD BioSciences Introduces Label-Free Live Cell Imaging Services for Bio-Research CD BioSciences
05-Jan-2023 CD BioSciences Introduces Various Solutions for Autophagic Cell Death Studies CD BioSciences
04-Jan-2023 Infex’s novel AMR drug candidate MET-X receives FDA QIDP designation Infex Therapeutics
04-Jan-2023 Tiziana Life Sciences Announces IND filed for Phase 2 Study of Milciclib in Combination with Gemcitabine for Non-Small Cell Lung Cancer Tiziana Life Sciences
04-Jan-2023 CD Bioparticles Announces Magnetofection Reagents for Gene Expression CD Bioparticles
04-Jan-2023 CD Bioparticles Introduces Hydrophobic Interaction Chromatography Resins for Purification of Macromolecules CD Bioparticles
04-Jan-2023 Creative Diagnostics Expands Its Monoclonal Antibodies Offering to Customers Creative Diagnostics
04-Jan-2023 Creative Diagnostics Introduces New Hemagglutination Inhibition Assay Services Creative Diagnostics
22-Dec-2022 OKYO Pharma Announces U.S. FDA Clearance of IND Application for OK-101 for the Treatment of Dry Eye Disease OKYO Pharma
22-Dec-2022 Kancera submits regulatory application to conduct clinical study in ovarian cancer and enters into collaboration with the Nordic Society of Gynaecological Oncology Kancera
21-Dec-2022 Innovative Antibody Discovered by RQ Bio Enters Clinic as Part of Antibody Combination Within 12 Months of Discovery RQ Bio